The unusual terms of Michael Mahoney’s move from Johnson & Johnson to the CO role at Boston Scientific were driven by J&J’s insistence on enforcing its stringent non-competition agreement with Mahoney, who ran its medical device & diagnostics operations, according to the Wall Street Journal. The unusual terms of Michael Mahoney’s move from Johnson & Johnson (NYSE:JNJ) to – eventually – the corner office at Boston Scientific Corp. (NYSE:BSX) were driven by J&J’s insistence on enforcing a stringent non-competition agreement, according to the Wall Street Journal.
